Trials / Completed
CompletedNCT02946307
Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease
A Prospective, Multi-center, Randomized, Controlled Clinical Trial, Assessing the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease in Chinese Population With Coronary Heart Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- ZhuHai Cardionovum Medical Device Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of RESTORE Paclitaxel eluting balloon in the treatment of Chinese patients with coronary heart disease and small vessel lesions in comparison with RESOLUTE Zotarolimus eluting stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restore DEB（dimeter>2.00 mm） | |
| DEVICE | Resolute DES | |
| DEVICE | Restore DEB（dimeter:2.00 mm） |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2018-12-01
- Completion
- 2019-05-01
- First posted
- 2016-10-27
- Last updated
- 2019-07-29
Locations
12 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02946307. Inclusion in this directory is not an endorsement.